Frank J. Fabio
Directeur Financier/CFO chez CERES VENTURES, INC.
Postes actifs de Frank J. Fabio
Sociétés | Poste | Début | Fin |
---|---|---|---|
CERES VENTURES, INC. | Directeur Financier/CFO | 29/04/2013 | - |
Historique de carrière de Frank J. Fabio
Anciens postes connus de Frank J. Fabio
Sociétés | Poste | Début | Fin |
---|---|---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Directeur Financier/CFO | 12/09/2008 | 09/01/2009 |
Secrétaire Général | 12/09/2008 | 09/01/2009 | |
RENOVACARE, INC. | Directeur Financier/CFO | 12/09/2008 | 09/01/2009 |
Secrétaire Général | 12/09/2008 | 09/01/2009 | |
SOLARWINDOW TECHNOLOGIES, INC. | Directeur Financier/CFO | 09/09/2008 | 09/01/2009 |
Secrétaire Général | 09/09/2008 | 09/01/2009 | |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Directeur Financier/CFO | - | 14/11/2007 |
Secrétaire Général | - | 14/11/2007 |
Formation de Frank J. Fabio
Pace University | Undergraduate Degree |
Long Island University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Director of Finance/CFO | 5 |
Corporate Secretary | 4 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
RENOVACARE, INC. | Health Technology |
SOLARWINDOW TECHNOLOGIES, INC. | Producer Manufacturing |
CERES VENTURES, INC. | Health Services |
Entreprise privées | 2 |
---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Finance |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
- Bourse
- Insiders
- Frank J. Fabio
- Expérience